They will be discussing the “Defense of Negligence Claims Involving Off-Label Use of Drugs and Devices.”
The session will focus on clinical decision-making, risk mitigation, the importance of informed consent in off-label drug and device use, and relevant cases and legal developments in this emerging area.
To learn more about the conference, click here.
